Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Net-Income-Including-Non-Controlling-Interests" stands at 6.37 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 2.83 Billion EUR for the item "Net Income Including Non Controlling Interests" represents an increase of 274.07 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 2.83 Billion EUR for the item "Net Income Including Non Controlling Interests" represents a decrease of -0.56 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 6.37 Billion EUR for the item "Net Income Including Non Controlling Interests" represents a decrease of -0.25 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 90.69 percent compared to the value the year prior.
The 1 year change in percent is 90.69.
The 3 year change in percent is -1.33.
The 5 year change in percent is -43.43.
The 10 year change in percent is 23.07.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income Including Non Controlling Interests | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income Including Non Controlling Interests | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income Including Non Controlling Interests | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income Including Non Controlling Interests | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income Including Non Controlling Interests | 280,205,508,085.11 |